4-(4-Bromophenyl)pyridine

Catalog No. :
ACOBUQ758
CAS No. :
39795-60-3
Molecular Formula :
C11H8BrN
Molecular Weight :
234.10

IUPAC Name:4-(4-bromophenyl)pyridine

4-(4-Bromophenyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$65.00Login to see priceIn stockInquiry
10g98%$126.00Login to see priceIn stockInquiry
25g98%$306.00Login to see priceIn stockInquiry
100g98%$1154.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(4-Bromophenyl)pyridine
IUPAC Name4-(4-bromophenyl)pyridine
MDL No.MFCD00956748
Molecular FormulaC11H8BrN
Molecular Weight234.10
SMILESBrC1=CC=C(C2=CC=NC=C2)C=C1
InChI KeyGYJBDJGUNDKZKO-UHFFFAOYSA-N
SynonymMFCD00956748 | 4-(4-Bromophenyl)pyridine | 4-(4-BROMO-PHENYL)-PYRIDINE | 10.14272/GYJBDJGUNDKZKO-UHFFFAOYSA-N.1 | BCP22853 | CS-W006114 | SY038030 | SCHEMBL1773352 | DTXSID501312251 | EN300-212989 | 4-(pyrid-4-yl)bromobenzene | A4540 | FT-0687528 | AM8575
CAS No.39795-60-3
PubChem CID616283

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOBUQ758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKXSD380 route compound structure diagram
    ACKXSD380589-87-7 In Stock
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACOBUQ758 route product structure diagram
    ACOBUQ75839795-60-3 In Stock
Inquiry

2. ACOBUQ758 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOZRV135 route compound structure diagram
    ACOZRV13519524-06-2 In Stock
  2. Plus
  3. ACEGJX062 route compound structure diagram
    ACEGJX0625467-74-3 In Stock
  4. Then
  5. ACOBUQ758 route product structure diagram
    ACOBUQ75839795-60-3 In Stock
Inquiry

Comments (0)